ScholarIQanswers from OpenAlex & ORCID
Filip Baert
ResearcherPublications, citations & collaboration network
Filip Baert is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Filip Baert have?
ScholarIQindexed works
Filip Baert has 248 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Filip Baert have?
ScholarIQcitation count
Filip Baert has 19,382 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Filip Baert?
ScholarIQh-index
Filip Baert has an h-index of 54 in OpenAlex.
What is the i10-index of Filip Baert?
ScholarIQi10-index
Filip Baert has an i10-index of 108 in OpenAlex.
What is the OpenAlex record for Filip Baert?
ScholarIQopenalex
The OpenAlex for Filip Baert is on the source record.
What are the most-cited papers on Filip Baert?
ScholarIQmost cited works
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Filip Baert, Maja Noman, Séverine Vermeire, Gert Van Assche, Geert D' Haens, An Carbonez, Paul Rutgeerts
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease
Julián Panés, Julián Panés, Damián García-Olmo, Gert Van Assche, Jean Frederic Colombel, Walter Reinisch, Daniel C. Baumgart, Axel Dignaß, Maria Nachury, Marc Ferrante, Lili Kazemi-Shirazi, Jean Charles Grimaud, Fernando de la Portilla, Eran Goldin, M Richard, Mary Carmen Díez, Ignacio Tagarro, Anne Leselbaum, Silvio Danese, Julián Panés, Julián Panés, Daniel C. Baumgart, Jean F. Colombel, Silvio Danese, Gert Van Assche, Walter Reinisch, Damián García-Olmo, Anton Stift, Jörg Tschmelitsch, Karl Mrak, Herbert Tilg, Irmgard Kroberger, André D’Hoore, Danny De Looze, Filip Baert, Paul Pattyn, Philippe Zerbib, Frank Zerbib, S Viennot, Jean‐Louis Dupas, P Orsoni, Xavier Hébuterne, Amine Rahili, Matthieu Allez, Yves Panís, Max Reinshagen, Roland Scherer, Andreas Sturm, Wolfgang Kruis, Daniel-Simon Duek, Matti Waterman, Adi Lahat-Zok, Oded Zmora, Hagit Tulchinsky, Yair Edden, Antonino Spinelli, Vito Annese, Imerio Angriman, Gabriele Riegler, Francesco Selvaggi, Bas Oldenburg, Lennard P. L. Gilissen, G Montfort, Mark Löwenberg, Adrianus Willem Bemelman, Raúl Almenara, María Dolores Martín‐Arranz, Mariano García‐Arranz, Javier Pérez Gisbert, Rosana Palasí, Carlos Taxonera Samsó, José Manuel Herrera Justiniano, Ricardo Rada, Ma Teresa Butrón, Daniel Carpio López, Antonio López–Sanromán, Joaquín Hinojosa de Val, Amparo Solana, F. Xavier González Argenté, C. Martínez Pastor, Héctor Guadalajara
Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
William J. Sandborn, Filip Baert, Silvio Danese, Željko Krznarić, Taku Kobayashi, Xiaopan Yao, Jingjing Chen, Maria Rosario, Siddharth Bhatia, Krisztina Kisfalvi, Geert D’Haens, Séverine Vermeire
A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
Maria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, Anthony de Buck van Overstraeten, Thomas Billiet, Filip Baert, Albert Wolthuis, Gert Van Assche, Maja Noman, Ilse Hoffman, André D’Hoore, Ann Gils, Paul Rutgeerts, Marc Ferrante